More than 140,000 bottles of cholesterol medication recalled: See the list

The FDA has issued a recall for Atorvastatin Calcium Tablets, a generic version of Lipitor, manufactured by Alkem Laboratories, Ltd.  (Photo by Tim Boyle/Getty Images)


The Food and Drug Administration (FDA) has issued a recall of over 140,000 bottles of  a cholesterol medication due to what the FDA says is "failed dissolution specifications." 

What we know:


The drug, Atorvastatin Calcium Tablets, a generic version of Lipitor, was manufactured by Alkem Laboratories, Ltd. India and distributed nationwide by Ascend Laboratories, LLC, in New Jersey.

Dig deeper:


Atorvastatin is a prescription statin medication that is prescribed to lower cholesterol, reducing the risk of heart disease, stroke, and other cardiovascular problems. It slows the production of cholesterol in the liver.

Recalled Atorvastatin (Lipitor) Calcium Tablets 

Atorvastatin Calcium Tablets USP, 10 mg, Rx Only  

90-count bottle (NDC 67877-511-90) 
500-count bottle (NDC 67877-511-05)
1000-count bottle (NDC 67877-511-10) 
 

Lot#: 25141249, Exp. Feb. 2027 
Lot#: 24144938, Exp. Nov. 2026 
Lot#: 24144868, Exp. Nov. 2026 
Lot#: 24144867, Exp. Nov. 2026 
Lot#: 24144458, Exp. Sep. 2026
Lot#: 24143994, Exp. Sep. 2026 
Lot#: 24142987, Exp. July 2026 
Lot#: 24143316, Exp. July 2026

Atorvastatin Calcium Tablets USP, 40 mg, Rx Only 

90-count (NDC 67877-513-90)
500-count (NDC 67877-513-05)
1000-count (NDC 67877-513-10)

Lot#: 25140933, Exp. Feb. 2027 
Lot#: 25140477, Exp. Dec. 2026 
Lot#: 24144254, Exp. Oct. 2026 
Lot#: 24144163, Exp. Sep. 2026 
Lot#: 24143995, Exp. Sep. 2026

Atorvastatin Calcium Tablets USP, 20 mg, Rx Only 

90-count(NDC 67877-512-90)
500-count (NDC 67877-512-05)
1000-count(NDC 67877-512-10)

Lot #: 25140150, Exp. Dec. 2026 
Lot #: 25140173, Exp. Dec. 2026 
Lot #: 25140172, Exp. Dec. 2026 
Lot #: 24144720, Exp. Nov. 2026 
Lot #: 24144798, Exp. Nov. 2026 
Lot #: 24144692, Exp. Oct. 2026 
Lot #: 24143755, Exp. Aug. 2026 
Lot #: 24143913, Exp. Aug. 2026 
Lot #: 24143754, Exp. Aug. 2026 
Lot #: 24143047, Exp. June 2026
Lot #: 24142936, Exp. July 2026 

Atorvastatin Calcium Tablets USP, 80 mg, Rx Only 

90-count(NDC 67877-514-90)
500-count(NDC 67877-514-05)

Lot#: 25140249, Exp. Dec. 2026 
Lot#: 25140247, Exp. Dec. 2026 
Lot#: 24144999, Exp. Nov. 2026 
Lot#: 24144942, Exp. Nov. 2026 
Lot#: 24144845, Exp. Nov. 2026 
Lot#: 24144713, Exp. Nov. 2026 
Lot#: 24144652, Exp. Oct. 2026 
Lot#: 24143898, Exp. Aug. 2026 
Lot#: 24143412, Exp. Aug. 2026
Lot#: 24143582, Exp. Aug. 2026


 

What's next:

The FDA, Alkem Laboratories, Ltd. India, and Ascend Laboratories, LLC have not issued information on what people who have the recalled medication should do.

The FDA’s website says:
 

The Source: The information in this article was taken from the Food and Drug Administration (FDA) recall website.  This story was reported from Orlando.


 

HealthRecallsConsumerNews